Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:5 Number:20 ISSN#:2563-5476
RCT
ACE Report #10003
Ace Report Cover Osteoarthritis

Etoricoxib versus placebo for knee osteoarthritis


How to Cite

OrthoEvidence. Etoricoxib versus placebo for knee osteoarthritis. ACE Report. 2018;7(5):20. Available from: https://myorthoevidene.com/AceReport/Report/10003

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial

Osteoarthritis Cartilage. 2017 Nov;25(11):1781-1791

Contributing Authors: AA Wright P Moss HAE Benson R Will

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

86 patients with symptomatic knee osteoarthritis were randomized to etoricoxib 60mg daily for 14 days or placebo for 14 days. Patients were assessed for outcome related to resting and dynamic pain, stiffness, function, and pressure pain threshold after 4 and 14 days of treatment. Results demonstrated significantly greater improvement after 14 days in the etoricoxib group compared to the placebo gr...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.